Loading...

News List

Nature Biotechnology | 抗体药物偶联物(ADCs):开创精准癌症治疗新纪元

2024-03-15


近期的研究表明,通过改进连接技术和开发新型药物载体,ADCs能够更有效地杀死癌细胞,同时减少对健康细胞的损害。抗体药物偶联物(Antibody-Drug Conjugates,简称ADCs),作为一种新兴的抗癌治疗方法,近年来在生物医药领域引起了广泛关注。ADCs通过将强效的抗癌药物与特异性抗体连接在一起,能够将药物直接输送至癌细胞,从而最大限度地提高疗效,同时减少对正常细胞的损害。

Pre: The oral version of Semaglutide was approved for domestic market, and clinical results showed that it can effectively reduce blood sugar and lose weight

Next: Nature Biotechnology | Antibody Drug Conjugators (ADCs) : ushering in a new era of precision cancer therapy

We would like to use cookies to better understand your use of this website, which will help improve your experience on future visits to the website. You can change this setting in your browser settings. For more information about the use of cookies, please refer to our Privacy Policy.